نتائج البحث - "Uitdehaag BM"

1

The MSOAC approach to developing performance outcomes to measure and monitor multiple sclerosis disability

المساهمون: Neurology, Amsterdam Neuroscience - Neuroinfection & -inflammation, Medical Research Council (MRC)

المصدر: Multiple Sclerosis Journal, 24(11), 1469-1484. SAGE Publications Ltd
Multiple Sclerosis (Houndmills, Basingstoke, England)
Multiple Sclerosis Outcome Assessments Consortium (MSOAC) 2018, ' The MSOAC approach to developing performance outcomes to measure and monitor multiple sclerosis disability ', Multiple Sclerosis Journal, vol. 24, no. 11, pp. 1469-1484 . https://doi.org/10.1177/1352458517723718

مصطلحات موضوعية: STATUS SCALE, medicine.medical_specialty, Multiple Sclerosis, Databases, Factual, IMPACT, Clinical Neurology, CONTRAST LETTER ACUITY, Measure (physics), Disability Evaluation, 03 medical and health sciences, 0302 clinical medicine, Physical medicine and rehabilitation, Outcome Assessment, Health Care, medicine, EMPLOYMENT, Humans, MS disability, performance outcome measures, data standards, clinical trial database, regulatory qualification, 030212 general & internal medicine, VALIDITY, SPEED, Functional composite, PROGRESSIVE MS, Science & Technology, Neurology & Neurosurgery, business.industry, Multiple sclerosis, Neurosciences, FUNCTIONAL COMPOSITE, 1103 Clinical Sciences, IMPAIRMENT, medicine.disease, Multiple Sclerosis Outcome Assessments Consortium (MSOAC), Clinical neurology, Neurology, Physical therapy, Neurosciences & Neurology, HEALTH, Neurology (clinical), 1109 Neurosciences, business, Life Sciences & Biomedicine, Original Research Papers, 030217 neurology & neurosurgery

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c0a745dfe2c0510c571629e202d3b03
https://research.vumc.nl/en/publications/fb260b55-8245-4745-81e8-76c5dc4e2019

2

Patient subgroup analyses of the treatment effect of subcutaneous interferon β-1a on development of multiple sclerosis in the randomized controlled REFLEX study

المؤلفون: Freedman MS, De Stefano N, Barkhof F, Polman CH, Uitdehaag BM, Casset Semanaz F, Hennessy B, Lehr L, Stubinski B, Jack DL, Kappos L., COMI , GIANCARLO

المساهمون: Freedman, M, De Stefano, N, Barkhof, F, Polman, Ch, Comi, Giancarlo, Uitdehaag, Bm, Casset Semanaz, F, Hennessy, B, Lehr, L, Stubinski, B, Jack, Dl, Kappos, L.

URL الوصول: https://explore.openaire.eu/search/publication?articleId=od_____10495::4276dbb64f8da4b72178d2bfa4bd79a9

3

Comparison of subcutaneous interferon beta-1a with glatiramer acetate in patients with relapsing multiple sclerosis (the REbif vs Glatiramer Acetate in Relapsing MS Disease [REGARD] study): a multicentre, randomised, parallel, open-label trial

المؤلفون: Mikol, Dd1, Barkhof, F, Chang, P, Coyle, Pk, Jeffery, Dr, Schwid, Sr, Stubinski, B, Uitdehaag, B, Ballario, Ch, Caceres, Fj, Correale, J, Cristiano, E, Garcea, Do, Leutic, Gg, Aicher, F, Barreira, Aa, Freedman, M, Grand'Maison, F, Jacques, F, Lee, L, Stefanelli, M, Edan, G, Pelletier, J, Berghoff, M, Keifer, R, Koehler, J, Hardiman, O, Comi, G, Mancardi, GIOVANNI LUIGI, Pozzilli, C, Trojano, Mp, Jongen, P, Uitdehaag, Bm, Belova, An, Boyko, An, Elchaninov, Ap, Kozlov, Va, Odinak, Mm, Shvarkov, Sb, Skoromets, Aa, Spirin, Nn, Stolyarov, Id, Vorobieva, Ov, Zavalishin, I, Arbizu, T, Fernandez, O, Izquierdo, G, Montalban, X, Goebels, N, Bates, D, Constantinescu, C, Turner, B, Bashir, K, Bever, Ct, Birnbaum, G, Brod, Sa, Carlini, W, Dunne, P, Elias, S, Estronza, N, Fox, E, Glyman, S, Gross, J, Guarnaccia, Jb, Gupta, A, Kaufman, M, Khan, O, Khatri, B, Kresa reahl, K, Lava, N, Leist, T, Markowitz, C, Mihai, C, Mikol, Dd, Miller, T, Panitch, H, Parry, G, Rammohan, Kw, Reder, A, Sheppard, C, Simsarian, Jp, Smiroldo, J, Spier, L, Thrower, B, Vollmer, T, Wendt, J, Wray, S, Wynn, D.

المساهمون: Radiology and nuclear medicine, Epidemiology and Data Science, Neurology, Neuroscience Campus Amsterdam 2008

المصدر: Mikol, D D, Barkhof, F, Chang, P, Coyle, P K, Jeffery, D R, Schwid, S R, Stubinski, B & Uitdehaag, B M J 2008, ' Comparison of subcutaneous interferon beta-1a with glatiramer acetate in patients with relapsing multiple sclerosis (the REbif vs Glatiramer Acetate in Relapsing MS Disease [REGARD] study): a multicentre, randomised, parallel, open-label trial ', Lancet Neurology, vol. 7, no. 10, pp. 903-914 . https://doi.org/10.1016/S1474-4422(08)70200-X
Lancet Neurology, 7(10), 903-914. Lancet Publishing Group

مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Multiple Sclerosis, Adolescent, Injections, Subcutaneous, Population, Placebo-controlled study, Relapsing-Remitting, drug therapy/pathology, Drug Administration Schedule, Injections, methods, law.invention, Disability Evaluation, Multiple Sclerosis, Relapsing-Remitting, Randomized controlled trial, law, Internal medicine, Adolescent, Adult, Confidence Intervals, Disability Evaluation, Disease Progression, Drug Administration Schedule, Female, Humans, Immunologic Factors, administration /&/ dosage, Injections, Subcutaneous, methods, Interferon-beta, administration /&/ dosage, Magnetic Resonance Imaging, methods, Male, Middle Aged, Multiple Sclerosis, drug therapy/pathology, Peptides, administration /&/ dosage, Retrospective Studies, Treatment Outcome, Confidence Intervals, medicine, Humans, Immunologic Factors, Glatiramer acetate, administration /&/ dosage, education, Retrospective Studies, education.field_of_study, Intention-to-treat analysis, business.industry, Interferon beta-1a, McDonald criteria, Glatiramer Acetate, Interferon-beta, Middle Aged, Magnetic Resonance Imaging, Treatment Outcome, Tolerability, Immunology, Disease Progression, Female, Neurology (clinical), Peptides, business, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::adf18e8a5ef741d37534d0198c937a14
https://doi.org/10.1016/s1474-4422(08)70200-x

View record from ScienceDirect

Find this article in full text from ProQuest

Full Text via ClinicalKey

4

MSIF Atlas of MS database update: multiple sclerosis resources in the world 2013

المؤلفون: Thompson, Aj, Browne, Po, Taylor, Bv, Battaglia, Ma, Pandit, L, Tremlett, H, Uitdehaag, Bm, Holloway, E

URL الوصول: https://explore.openaire.eu/search/publication?articleId=od______1820::cdc226e59837ba3748778581510a1023
http://hdl.handle.net/11365/1059690

5

Consensus recommendations for MS cortical lesion scoring using double inversion recovery MRI

المساهمون: Anatomy and neurosciences, Radiology and nuclear medicine, Neurology, Epidemiology and Data Science, NCA - Multiple Sclerosis and Other Neuroinflammatory Diseases, Geurts, Jjg, Roosendaal, Sd, Calabrese, M, Ciccarelli, O, Agosta, F, Chard, Dt, Gass, A, Huerga, E, Moraal, B, Pareto, D, Rocca, Ma, Wattjes, Mp, Yousry, Ta, Uitdehaag, Bmj, Barkhof, F, on behalf of the MAGNIMS, Consortium, Filippi, M

المصدر: Neurology, 76(5), 418-424. Lippincott Williams and Wilkins
Geurts, J J G, Roosendaal, S D, Calabrese, M, Ciccarelli, O, Agosta, F, Chard, D T, Gass, A, Huerga, E, Moraal, B, Pareto, D, Rocca, M A, Wattjes, M P, Yousry, T A, Uitdehaag, B M J & Barkhof, F 2011, ' Consensus recommendations for MS cortical lesion scoring using double inversion recovery MRI ', Neurology, vol. 76, no. 5, pp. 418-424 . https://doi.org/10.1212/WNL.0b013e31820a0cc4